Liminatus Pharma's total assets for Q3 2025 were $1.34M, a decrease of -29.67% from the previous quarter. LIMN total liabilities were $2.99M for the fiscal quarter, a -72.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.